Acquired Immunodeficiency Syndrome: all 3,037 studies
Page 3 of 31. Open to participants first (307), then studies with results posted, then the rest; newest registration first within each.
- The TRIple Elimination Model Of Mother-to-child Transmission Program (TRI-MOM)RecruitingNCT05951751Not applicable
- Oregon PrEP at Home StudyRecruitingNCT05949203
- Improving HIV Care Engagement Among Ugandan Adolescent Girls and Young Women: The Kisoboka Mukwano InterventionEnrolling by invitationNCT05947539Not applicable
- Mesenchymal Stem Cells Treatment for AIDS Patients at Late StageRecruitingNCT05939167Phase 1/2
- ORCHID: An Online Intervention for Persons With HIV (Miami)Enrolling by invitationNCT05935644Not applicable
- Mitigating the Impact of Stigma and Shame Among People Living With HIV and Substance Use DisordersRecruitingNCT05934305Not applicable
- B. Infantis Supplementation to Improve Immunity in Infants Exposed to HIVRecruitingNCT05923333Not applicable
- Peer-led Implementation of TB-HIV Education and Adherence Counseling in UgandaRecruitingNCT05917210Not applicable
- Mesenchymal Stem Cells for Immune Non-responder Patients With HIV InfectionRecruitingNCT05872659Early Phase 1
- A Clinical Trial to Evaluate the Safety and Immunogenicity of a Prophylactic HIV Vaccine CandidateNot yet recruitingNCT05863585Phase 1
- Identifying Challenges to Healthy Aging in Persons With Human Immunodeficiency Virus (HIV) Age 50 and OlderRecruitingNCT05858034Not applicable
- Inflammation and Depression in People With HIVRecruitingNCT05849038Phase 2
- Clinical Outcomes in HIV With ComorbiditiesRecruitingNCT05824130
- Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDSRecruitingNCT05814432Phase 3
- Efficacy, Acceptability and Safety of Event-driven HIV PrEP Using TAF/FTC in MSM in Thailand and France.RecruitingNCT05813964Phase 3
- RCT of an Intersectional Stigma Intervention to Sustain Viral Suppression Among Women Living With Serious Mental Illness and HIV in BotswanaRecruitingNCT05807867Not applicable
- V+PSF-M for Tobacco Cessation in HIV Care in IndiaRecruitingNCT05786547Phase 3
- Methamphetamine, PrEP, and Intersectional Stigma StudyNot yet recruitingNCT05784467Not applicable
- LA PrEP Impact and Cost-effectiveness (TEAMS)RecruitingNCT05774548Not applicable
- Awareness of Osteoporosis in HIV PatientsNot yet recruitingNCT05769413
- A Mobile Gaming App to Improve Adherence to PrEPRecruitingNCT05762705Not applicable
- Optimization of a Behavioral Intervention to Increase Physical Activity in Older Adults Living With HIVRecruitingNCT05752500Not applicable
- Alcohol and "Heat of the Moment" Sexual Decision MakingRecruitingNCT05729256Not applicable
- Botswana Smoking and Abstinence Reinforcement TrialEnrolling by invitationNCT05694637Phase 4
- Increasing PrEP With Trans Women in the Deep SouthRecruitingNCT05689281Not applicable
- Effectiveness of Relationship Education for Reducing HIV Incidence Among Men Who Have Sex With MenRecruitingNCT05678556Not applicable
- Bring BPaL2Me Trial Comparing Nurse-Led RR-TB Treatment to Physician-Led RR-TB TreatmentRecruitingNCT05671718Not applicable
- Optimizing Evidence-based HIV Prevention Targeting People Who Inject Drugs on PrEPRecruitingNCT05669534Phase 4
- Influence of Resentment and Forgivingness on Quality of Life in People Living With HIVRecruitingNCT05660148
- Text Education About Cardiovascular Health and HIV (TEACH-HIV)RecruitingNCT05642858Not applicable
- Trial of a Harm Reduction Strategy for People With HIV Who Smoke CigarettesRecruitingNCT05642715Not applicable
- Pharmacokinetics and Safety of DolutegravIr in NeonateRecruitingNCT05590325Phase 1/2
- SV2A & TSPO PET Imaging Measures to Reveal Mechanisms of HIV Neuropathogenesis During Antiretroviral TherapyRecruitingNCT05586581Phase 1/2
- Reducing Mortality in Adults With Advanced HIV Disease (REVIVE)RecruitingNCT05580666Phase 3
- Low Dose Naltrexone for Pain in Patients With HIVRecruitingNCT05537935Phase 4
- TelePrEP for At-risk Youth in ColoradoRecruitingNCT05520905Not applicable
- Women SHINE: Addressing Syndemics and HIV Among Women Through Tech-Based Peer EngagementRecruitingNCT05509959Not applicable
- A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIVRecruitingNCT05495906Phase 4
- Efficacy and Tolerability of DTG Plus 3TC in HIV Infected Adults With Virologically Suppression and TDF ToxicityNot yet recruitingNCT05493969Phase 4
- Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)Not yet recruitingNCT05473325
- Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...RecruitingNCT05470491Phase 1/2
- Baricitinib for Reduction of HIV - CNSRecruitingNCT05452564Phase 2
- Efficacy and Safety of Ainuovirine Treating With AIDS PatientsRecruitingNCT05420246
- Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment InterruptionRecruitingNCT05419024Phase 2
- Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi SarcomaNot yet recruitingNCT05411237Phase 3
- Systems Analysis and Improvement Approach to Improve Integration of HIV Prevention and Treatment ServicesRecruitingNCT05404958Not applicable
- Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood SpotRecruitingNCT05390424Not applicable
- A Randomized Clinical Trial to Evaluate Solutions for the Management of Virologic Failure on TLD in Sub-Saharan AfricaRecruitingNCT05373758Not applicable
- Study of Entry and Continuation in Care for People Living With HIV in French GuianaRecruitingNCT05354934
- Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver DiseaseRecruitingNCT05330923
- Phase II Trial of ART + Dual bNAbs vs. ART + Placebo During Primary HIV-1 Infection-impact on Post-ART ControlRecruitingNCT05300035Phase 2
- The Positively Dance Pilot Program for Women Living With HIVRecruitingNCT05295797Not applicable
- Can Undetectable (Viral Load) = Untransmissible (Virus) Change the Life Course of Adolescents Living in AfricaEnrolling by invitationNCT05278559
- Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIVRecruitingNCT05266898Phase 4
- Practice Facilitation as a Strategy to Improve Alcohol Treatment Adoption and Implementation in HIV CareRecruitingNCT05241990Not applicable
- Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive DonorsRecruitingNCT05159466
- Optimizing Tobacco Treatment Delivery for People Living With HIVRecruitingNCT05019495Not applicable
- Effectiveness of a Mobile-based HIV Prevention Intervention Involving Incentive Policy for Doctors in Liangshan, ChinaNot yet recruitingNCT05015062Not applicable
- The Dreamer Girls Project: Adaptation of SISTA/SIHLE for HIV/AIDS and Substance Abuse Prevention Among Black Adolescent GirlsNot yet recruitingNCT05014074Not applicable
- Cefixime Clinical TrialRecruitingNCT04958122Phase 3
- Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi SarcomaRecruitingNCT04941274Phase 1/2
- Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIVRecruitingNCT04902443Phase 1
- Safety and Immunogenicity Following Meningococcal and Pneumococcal Immunization Among Adult People Living With HIVRecruitingNCT04875819Phase 4
- Pharmacokinetics of Twice or Once Daily DTG (50mg) in Children With HIV and TBRecruitingNCT04746547Phase 4
- Pre- and Post-treatment Lung Microbiota, Metabolome and Immune Signatures at the Site of Disease in Patients With Active Pulmonary TuberculosisRecruitingNCT04700579
- Observational Study on Patients With HIV/AIDS(OSPWH)RecruitingNCT04667026
- Sequential Analysis Before and After Treatment Initiation to Unravel the Role of Naturally Occurring Extracellular Vesicles in HIV InfectionRecruitingNCT04653610
- Measuring Adverse Pregnancy and Newborn Congenital OutcomesRecruitingNCT04405700
- Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)RecruitingNCT04375800Phase 2
- SCOPE Analytic Treatment Interruption ProtocolRecruitingNCT04359186Not applicable
- Action for Brain Health Now: Ready, Set, GoNot yet recruitingNCT04345484Not applicable
- HIV-HEART Aging StudyRecruitingNCT04330287
- A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).RecruitingNCT04319367Phase 2
- HIV Study on MEasuring the Reservoir on Cellular Level to CUre InfectionRecruitingNCT04305665
- PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi SarcomaRecruitingNCT04303117Phase 1/2
- Probiotic Supplementation for Those Immune Non-responders With HIV-1 InfectionRecruitingNCT04297488Not applicable
- Fostemsavir Compassionate Use Named Patient Program for the Treatment of Human Immunodeficiency Virus 1 (HIV-1)AvailableNCT04233047
- Italian Registry of HIV-1 Infected Patients With Drug-RESistant Virus to Reverse Transcriptase Inhibitors, InteGrasE and Viral Protease.RecruitingNCT04098315
- The Effect of Arsenic Trioxide on Eliminating HIV-1 Reservoir Combined With cARTRecruitingNCT03980665Phase 1
- HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSILNot yet recruitingNCT03947775Phase 2
- Outcomes Mandate National Integration With Cannabis as MedicineRecruitingNCT03944447Phase 2
- Lifestyle Modification Programme for HIV-infected Individuals With Fatty LiverRecruitingNCT03913351Not applicable
- Dolutegravir Plus Lamivudine Simplified TherapyRecruitingNCT03884673
- Short-term Steroid Therapy in Patients With P. Jirovecii Pneumonia Due to HIV / AIDSEnrolling by invitationNCT03856229Not applicable
- Observational Pharmaco-Epidemiology Research & AnalysisRecruitingNCT03813862
- An mHealth Intervention to Improve Outcomes for Women With HIV/AIDSRecruitingNCT03738410Not applicable
- Nice Human Immunodeficiency Virus (HIV) CohortRecruitingNCT03690063
- Simplified Treatment of Anti-retrovirus in China (C-STAR)RecruitingNCT03603977
- GSK1265744 (Cabotegravir, CAB) for Named Patient/Compassionate Use in HIVAvailableNCT03462810
- Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman DiseaseRecruitingNCT03300830
- The Effect of Chimeric Antigen Receptor (CAR)-T Cell Therapy on the Reconstitution of HIV-specific Immune FunctionRecruitingNCT03240328Phase 1
- Vedolizumab Treatment in Antiretroviral Drug Treated Chronic HIV InfectionRecruitingNCT03147859Phase 2
- Project I Test: Implementing HIV Testing in Opioid Treatment ProgramsRecruitingNCT03135886Not applicable
- Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected IndividualsRecruitingNCT03132311Phase 4
- Quality of Care in French HIV Infected PatientsRecruitingNCT02898987
- Feasibility of an Ingestible Sensor System to Measure PrEP Adherence in YMSMNot yet recruitingNCT02891720Not applicable
- EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIVEnrolling by invitationNCT02699736
- Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC VirusRecruitingNCT02479698Phase 2
- Comparative Autoantibody and Immunologic Cell Marker StudyEnrolling by invitationNCT02422875
- German Centre for Infection Research HIV Translational PlatformRecruitingNCT02149004